Menu
Back to User profile » Prof. Dr. Jonathan Corren
Papers published by Prof. Dr. Jonathan Corren:
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types
Panettieri R Jr, Lugogo N, Corren J, Ambrose CS
Journal of Asthma and Allergy 2024, 17:219-236
Published Date: 19 March 2024
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
Laidlaw TM, Menzies-Gow A, Caveney S, Han JK, Martin N, Israel E, Lee JK, Llanos JP, Martin N, Megally A, Parikh B, Vong S, Welte T, Corren J
Journal of Asthma and Allergy 2023, 16:1053-1054
Published Date: 27 September 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Laidlaw TM, Menzies-Gow A, Caveney S, Han JK, Martin N, Israel E, Lee JK, Llanos JP, Martin N, Megally A, Parikh B, Vong S, Welte T, Corren J
Journal of Asthma and Allergy 2023, 16:915-932
Published Date: 4 September 2023
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
Corren J, Jackson DJ, Casale TB, Borish L, Rabe KF, Busse WW, Maspero JF, Jackson DJ, Daizadeh N, Altincatal A, Radwan A, Khodzhayev A, Djandji M, Jacob-Nara JA, Rowe PJ, Deniz Y
Journal of Asthma and Allergy 2023, 16:249-260
Published Date: 7 March 2023
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
Corren J, Saini SS, Gagnon R, Moss MH, Sussman G, Jacobs J, Laws E, Chung ES, Constant T, Sun Y, Maloney J, Hamilton JD, Ruddy M, Wang CQ, O’Brien MP
Journal of Asthma and Allergy 2021, 14:1045-1063
Published Date: 16 August 2021
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
Emson C, Corren J, Sałapa K, Hellqvist Å, Parnes JR, Colice G
Journal of Asthma and Allergy 2021, 14:91-99
Published Date: 3 February 2021
Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
Corren J, Karpefors M, Hellqvist Å, Parnes JR, Colice G
Journal of Asthma and Allergy 2021, 14:1-11
Published Date: 11 January 2021
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function
Pavord ID, Siddiqui S, Papi A, Corren J, Sher LD, Bardin P, Langton D, Park HS, Rice MS, Deniz Y, Rowe P, Staudinger HW, Patel N, Ruddy M, Graham NMH, Teper A
Journal of Asthma and Allergy 2020, 13:701-711
Published Date: 16 December 2020
Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma
Tan RA, Corren J
Drug Design, Development and Therapy 2014, 8:1555-1561
Published Date: 30 September 2014
Mometasone furoate in the management of asthma: a review
Ricardo A Tan, Jonathan Corren
Therapeutics and Clinical Risk Management 2008, 4:1201-1208
Published Date: 5 December 2008